Psychedelic retreats and tourism

1. Introduction

Version followed: the clinician's harm-reduction and integration role for clients attending psychedelic retreats outside regulated care. It is built on the Psychedelic Harm Reduction and Integration (PHRI) stance of Gorman et al. (2021) (from the published abstract; the paper's detailed procedures are not reproduced here [uncertain]), the structure of Oregon Psilocybin Services (preparation, administration, optional integration), the Chacruna Institute's Ayahuasca Community Guide for the Awareness of Sexual Abuse (first version 19 Nov 2018), and the published safety and harm data listed under Sources. Primary or major sources include: the JAMA Network Open retreat-safety study (McGuire et al. 2026, abstract via institutional repository), the PLOS ONE 2025 landscape analysis (abstract), the 2008 Dutch Opium Act listing (Staatsblad) and truffle status (DutchNews), Jamaican government statements (2021, 2024), the 2015 and 2018 Peru killings (CBC; wire report), and Indigenous organisations' own statements (UMIYAC 2019; Fifth Indigenous Ayahuasca Congress letter via ICEERS 2025). Legal status in Jamaica, the Netherlands, Peru and Brazil rests on secondary reports and is marked [uncertain].

What it is. "Psychedelic retreats and tourism" is not a therapy. It is a commercial and ceremonial sector. People travel to residential programmes, usually lasting from one night to several weeks, where facilitators, shamans or healers give psychoactive plants or compounds (ayahuasca, psilocybin, San Pedro/peyote, ibogaine, and sometimes synthetic drugs such as MDMA or ketamine). Programmes often add yoga, meditation, group sharing, art activities, lifestyle workshops and some form of "integration" [uncertain: secondary, unverified]. Most advertised retreats focus on general wellness, and some describe themselves as religious [source: Neitzke-Spruill et al. 2025, PLOS ONE, abstract]. Retreats cluster in places where the substances are legal, tolerated or unregulated: ayahuasca in Peru, Costa Rica, Brazil and Colombia, and psilocybin mainly in the Netherlands and Jamaica. A 2025 PLOS ONE landscape analysis (Neitzke-Spruill et al.) identified 298 retreat organisations advertising online (July to December 2023), running 440 physical locations: 130 in the US and 310 elsewhere. Ayahuasca was the most common substance, followed by psilocybin and San Pedro, offered "at various price points". [source: Neitzke-Spruill et al. 2025, PLOS ONE 20(5), abstract]

Clinician's role. The clinician does not refer to, endorse, choose or facilitate any retreat, and does not supply substances or dosing advice. The role is to assess risk, help the client make an informed decision (including the decision not to go), plan for safety, support integration afterwards, and treat harms. Gorman et al. describe this as replacing assessment centred on adverse outcomes and abstinence-only stances with "compassionate, destigmatizing acceptance of patients' choices". [source: Gorman et al. 2021, abstract]

How change is thought to happen. Retreat operators and participants say that the acute experience, ceremony and community produce insight or emotional release. The clinician's working model is narrower: much of the lasting benefit, and the prevention of lasting harm, depends on preparation (realistic expectations, medical and psychiatric screening, sexual-safety and emergency planning) and on integration (making sense of the experience, managing after-effects, and turning insight into considered change). In the Global Ayahuasca Survey, 55.9% of 10,836 respondents reported mental-health effects in the weeks or months after use. Most saw these as part of growth, but about 12% sought professional support. [source: Bouso et al. 2022] [synthesis: the integration-centred model]

Legal and regulatory status (as of the sources' dates).

United States: virtually all retreat substances (psilocybin mushrooms, ayahuasca, MDMA, LSD) are illegal under federal law, and no psychedelic is FDA-approved. The FDA declined MDMA for PTSD in 2024. A 2026 executive order directs the FDA to speed reviews. [source: AP via WTOP, 2026] Oregon has run a state-regulated psilocybin programme since 2023 under ORS 475A. It uses licensed service centres and facilitators, requires clients to be 21 or older, and needs no prescription. Psilocybin remains federally Schedule I. [source: Nevada PMWG fact sheet on Oregon Psilocybin Services, 2024] Some groups claim a religious exemption, but AP reports that only a handful have formally obtained one. [source: AP 2026]
Peru: ayahuasca is protected as part of Indigenous tradition; a secondary legal explainer cites a 2008 Ministry of Culture declaration of traditional ayahuasca use as national cultural heritage. [source: The Psychedelic Journal (mindmedicinelaw.com), 2026; uncertain: secondary, unverified against the declaration] On 23 Jan 2025 the US Embassy advised US tourists to avoid ayahuasca and kambo, citing fatalities, serious medical complications and crimes linked to retreat centres. [source: DoubleBlind 2025, secondary report of the advisory] [uncertain]
Costa Rica: on 28 Jan 2025 the Ministry of Health warned against ayahuasca and ibogaine at retreats, stating the substances lack sanitary registration, which the article says makes them illegal under national rules. There is no formal licensing system for retreat centres, and the Ministry urges reporting of unlicensed retreats. [source: DoubleBlind 2025]
Netherlands: a decree of 17 November 2008, in force from 1 December 2008, added mushrooms that naturally contain psilocin or psilocybin (fresh or dried; the explanatory note counts 186 species) to List II of the Opium Act [source: Staatsblad 2008, 486]. Truffles (sclerotia) are not mentioned in that listing; secondary reporting says they were deliberately left out after an independent advisory report and are grown and sold legally, mainly through smart shops, without a licensing or quality-control regime, and that the 2008 ban followed several high-profile tourist incidents [source: DutchNews (Pascoe, 4 Jan 2021)] [uncertain: secondary; check current Dutch law]. Retreats rely on this truffle exemption.
Jamaica: in July 2021 the Minister of Agriculture and Fisheries said Jamaica had never passed laws making psilocybin illegal, that growing it was legal, that cultivation regulations were still awaited, and that interim protocols covered importing mushroom material through the Plant Quarantine Division [source: Jamaica Information Service, 18 Jul 2021]. In August 2024 the Ministry of Health and Wellness warned that psilocybin products can be dangerous to health and said it had not approved any for sale; the report describes the drug as sitting in a grey area with no licensing, and notes a National Council on Drug Abuse call to amend the Dangerous Drugs Act to regulate it [source: Caribbean Today, 27 Aug 2024]. Retreats therefore operate without a specific licensing framework [source: The Psychedelic Journal (mindmedicinelaw.com), reviewed 2026] [uncertain: unverified against the statute; a client should confirm current law with local counsel].
Brazil: religious ayahuasca use by recognised churches (for example União do Vegetal and Santo Daime) is protected under federal drug-policy resolutions dating from the late 1980s and reinforced in 2010; the protection is tied to registered religious organisations, not secular ayahuasca tourism. [source: The Psychedelic Journal (mindmedicinelaw.com)] [uncertain: secondary, unverified against the resolutions]

2. Framework

This is not a manualised protocol. The phases below are the clinician's own sequence [synthesis]. They borrow the preparation, administration and integration structure that regulated programmes use [source: Oregon Psilocybin Services fact sheet], and the assessment, preparation and difficult-experience components named by PHRI [source: Gorman et al. 2021, abstract]. Format: individual, in person or by video. Session counts are illustrative [synthesis].

Phase	Goals	Typical sessions	Move on when
A. Disclosure and assessment	Make it safe to disclose plans. Clarify motives and expectations. Screen medical, psychiatric, medication, trauma and substance history.	1–2	Risk picture complete; client has heard any strong medical or psychiatric contraindications; prescriber contact agreed where relevant.
B. Informed decision	Lay out risks, legal exposure and alternatives (regulated trials or programmes, or not going). Client decides.	1	Client has made an explicit, documented choice. If they will not go, move to ordinary therapy goals.
C. Preparation and safety planning	Review the retreat's due diligence. Plan sexual-safety boundaries, emergencies, transport and contacts. Prepare for difficult experiences. Plan aftercare.	1–3	Written safety and support plan in place; companion or contact named; return check-in booked.
D. The retreat (clinician absent)	No contact by default, or a pre-agreed emergency route only.	—	Client has returned.
E. Return triage	Screen for acute distress, suicidality, psychosis, abuse disclosures, medical problems and medication restart.	1, within the first days	Acute risks managed or referred. Oregon's programme requires facilitator follow-up within 72 hours, a useful benchmark. [source: Oregon fact sheet]
F. Integration	Process the experience. Separate insight from impulse. Delay major decisions. Consolidate change.	3–8+, open-ended	Experience is narratively coherent, after-effects are settling, and changes are chosen deliberately.
G. Harm-focused treatment (if needed)	Trauma, sexual-abuse sequelae, persistent anxiety or depersonalisation, psychosis follow-up, grief.	As indicated	Per the evidence-based treatment chosen.

Strong reasons to advise against attending, drawn from what retreats themselves exclude and from death and adverse-event data: psychotic disorder or a tendency to psychosis; serious physical illness or cardiovascular disease; taking antidepressants or other interacting medication without medical oversight; anxiety disorders or physical health conditions (both predicted adverse psychological effects); and a past substance use disorder (which predicted adverse physical effects). [source: ICEERS / Suárez Álvarez 2023; AP 2026; Bouso et al. 2022] Personal or family history of bipolar disorder, suicidality, pregnancy, and unstabilised severe trauma are further cautions [synthesis, mirroring common trial exclusion practice].

3. Guiding principles

Non-judgemental acceptance of the client's choice [source: Gorman et al. 2021]. Clients disclose more when they don't expect a lecture, so state neutrality early.
Harm reduction, not facilitation [synthesis]. You give general risk information and safety planning. You never recommend a provider, source, substance, dose or schedule.
Autonomy plus candour [synthesis]. Respect the decision, but say clearly when you think the risk is high (for example, psychosis history or interacting medication).
Medical issues belong to medical professionals [synthesis]. Medication changes and medical clearance go through the prescriber or physician, never through you or the retreat.
Self-report screening is weak [source: AP 2026: all surveyed retreats relied on self-disclosure]. Help the client disclose fully to any provider, and don't assume the retreat will catch a risk.
Power and sexual safety are central [source: Chacruna guide]. Abuse in ceremonies is an abuse of power. Plan for it the way you would plan for any medical risk.
Healers are human [source: Chacruna guide: "He's a Shaman, Not a Saint!"]. Help clients question idealised images of shamans, gurus or facilitators.
Integration takes time [source: Chacruna guide advises integration time before sexual or romantic decisions; synthesis extends this to all major decisions]. Discourage big life changes made in the afterglow.
Difficult experiences are common and usually workable, but not always [source: Bouso et al. 2022]. Normalise them without minimising, and screen for the minority who need clinical care.
Cultural humility [source: Chacruna guide on cross-cultural misreadings; ICEERS on supporting Indigenous communities]. Don't interpret ceremonial meanings for the client, and don't treat Indigenous traditions as a product.
Stay in scope and document [synthesis]. Keep notes on risk discussions and decisions, check your professional body's rules on illegal-drug disclosures, and get supervision.
Legal honesty [source: AP 2026 on unproven religious-exemption claims]. Tell clients that a retreat's legal claims may not protect them, and know your own jurisdiction's duties.

4. Intervention inventory

Note: no published step-by-step clinical protocol for retreat clients was found; the PHRI components are taken from the published abstract. Each intervention below names the source for its content. Steps and wording are [synthesis] unless a source is cited. All example language is illustrative.

4.1 Opening the door to disclosure

Purpose / when: whenever a client mentions psychedelics, a "plant medicine" trip or a retreat, or you suspect they are planning one. This puts the PHRI stance of non-stigmatising acceptance into practice. [source: Gorman et al. 2021, abstract]
Steps: (1) Ask routinely about psychedelic use, past and planned, as part of substance history. (2) Say what you will and won't do: no judgement, no facilitation, and the limits of confidentiality. (3) Ask open questions about what they have read, booked or been offered. (4) Thank them for telling you.
Example language (illustrative): "Lots of people are looking into retreats now. I won't try to talk you in or out of it. I'd like to help you think it through safely. Can you tell me what you're considering?"
Watch for: guardedness, a sense that you would disapprove, or a decision that is already fixed. It's working if the client gives concrete details (where, who, what substance, when) without defensiveness.

4.2 Motivation, expectation and meaning assessment

Purpose / when: Phase A. Unrealistic hopes (a cure in one weekend, reliving trauma to "get it out") raise the risk of disappointment and destabilisation. [synthesis]
Steps: (1) Ask what they hope will change and why now. (2) Ask where the idea came from (friends, social media, marketing). (3) Ask what they would do if nothing changed, or if it made things worse. (4) Ask whether a life crisis (bereavement, breakup, suicidal period) is driving the timing. (5) Reflect any pattern of looking for a single rescue.
Example language (illustrative): "If you came back and felt exactly the same, what would that mean to you?"
Watch for: retreat-as-last-resort thinking combined with suicidality, and marketing promises ("connect with your higher self" was used to promote the Miami Beach retreat where a participant died [source: CBS Miami 2026]). It's working if expectations become more modest and the client can name goals that therapy can also work on.

4.3 Medical and psychiatric risk screen

Purpose / when: Phase A, before any planning. Retreat screening relies on what clients tell them [source: AP 2026], and severe outcomes cluster in people with pre-existing risks [source: ICEERS / Suárez Álvarez 2023].
Steps: (1) Psychiatric history: psychotic disorder or psychotic-like episodes (personal and family), bipolar features, current and past suicidality, anxiety disorders, dissociative symptoms, eating disorders, substance use disorder. (2) Physical: cardiovascular disease or structural heart conditions (ICEERS reports a death in a man with Marfan syndrome), serious illness, seizures, pregnancy. (3) Trauma history and current stability, especially sexual trauma, given the abuse risk below. (4) Past psychedelic experiences and how they went. (5) Score current symptoms with your usual validated measures. (6) Summarise the risk level openly with the client. [source: ICEERS; Bouso et al. 2022 for anxiety, physical health and SUD as predictors] [synthesis: the checklist structure]
Example language (illustrative): "Some health conditions make these experiences much riskier, and retreats mostly rely on you to tell them. Let's go through them carefully."
Watch for: minimising or plans to hide conditions from the retreat. If psychosis history or serious cardiac disease is present, say plainly that you advise against going and recommend medical review. It's working if the client gives a full history and agrees to a physician's review where indicated.

4.4 Medication review and prescriber liaison (general terms only)

Purpose / when: any client taking prescribed or over-the-counter medication, supplements or other drugs. ICEERS lists mixing certain medications "such as antidepressants" as a contraindication for ayahuasca. In a JAMA Network Open interview study of 49 organisations advertising retreats (2023), 43 (87.8%) required or recommended a medication washout, with rules that varied widely; the authors flag some washout practices as possibly increasing risk. AP reports no professional supervision of that step. [source: ICEERS / Suárez Álvarez 2023; McGuire et al. 2026, abstract; AP 2026]
Steps: (1) List every medication and supplement. (2) Explain in general terms that some psychiatric and other medications can interact dangerously with retreat substances, and that stopping a medication can itself cause withdrawal or relapse. (3) Do not advise on stopping, tapering or timing; refer the client to their prescriber. (4) With consent, contact the prescriber. (5) Make a relapse-monitoring plan if the prescriber agrees to a change. (6) Plan when medication will restart after the retreat, again set by the prescriber. [synthesis]
Example language (illustrative): "I can't tell you whether or how to stop anything, and the retreat shouldn't either. That's a decision for your prescriber, who knows your history."
Watch for: a client stopping antidepressants abruptly because the retreat told them to, or mood relapse before travel. It's working if the prescriber is involved and the client is not making medication changes alone.

4.5 Informed-decision conversation

Purpose / when: Phase B. This mirrors the informed consent and bill of rights in regulated programmes. [source: Oregon Psilocybin Services fact sheet] [synthesis: application to unregulated retreats]
Steps: (1) Summarise the client's risk profile. (2) Cover general risks: common acute physical effects (69.9% reported acute effects, mainly vomiting), post-use psychological effects, rare deaths, sexual abuse, crime, and the lack of regulation. [source: Bouso et al. 2022; ICEERS; Chacruna; DoubleBlind on US Embassy and Costa Rica warnings] (3) Cover legal exposure in the destination and at home. (4) Name alternatives: not going, regulated programmes where legal, clinical trials, and non-drug therapies. (5) Let the client decide, and record the discussion.
Example language (illustrative): "Here's what the research and the reported incidents show, and here's what I see in your own situation. Then it's your call."
Watch for: feeling coerced either way. It's working if the client can explain the main risks back in their own words.

4.6 Retreat due-diligence review

Purpose / when: Phase C, if the client is going. You help the client question the provider. You do not vet or endorse it. [synthesis: role] [source: AP 2026 and Chacruna guide for the questions]
Steps: Help the client get written answers to these questions. (1) What are the medical staff's training and roles, and what equipment do they have for emergencies? (2) How far is the nearest hospital, and how would someone get there? (3) Do staff or facilitators take substances during ceremonies? (AP reports that some do, which could impair emergency response.) (4) Is screening more than self-report, and who reviews it? (5) How much preparation and aftercare time is offered? (6) Are experienced women present to support female participants? Is there a written abuse-prevention and complaints policy? (7) Are any substances given beyond the advertised one? (ICEERS links deaths to tobacco preparations, scopolamine-containing admixture plants and a synthetic tryptamine taken after ayahuasca.) (8) What legal basis do they claim? (9) What are the refund rules, and what does the waiver say? (10) Check independent reviews and past participants, and ask women in particular. [source: AP 2026; Chacruna; ICEERS]
Example language (illustrative): "Let's write down the questions to send them. How they answer is as important as what they say."
Watch for: vague answers, no medical plan, pressure to book quickly, claims that screening is unnecessary, or reviews that seem curated. It's working if the client changes plans or chooses more carefully when the answers are inadequate.

4.7 Sexual-safety and boundary planning

Purpose / when: every client, especially women and anyone with a history of sexual trauma. Chacruna notes that many women seek healing for past sexual trauma, which makes abuse especially harmful. [source: Chacruna guide]
Steps: (1) Go through the Chacruna warning signs (listed in the Harm account). (2) Agree personal rules: bring a trusted companion, and don't take individual or "special" treatments alone with a healer. (3) Rehearse saying no and stopping any treatment. (4) Agree clothing boundaries. Chacruna states that standard cleansing practices do not require touching private areas or removing clothing beyond comfort. (5) Treat extra substances offered privately as a red flag. (6) Agree to wait until after integration before any romantic or sexual involvement with staff or participants. (7) Explain the freeze response, and that reporting later is still possible. [source: Chacruna guide]
Example language (illustrative): "If anyone offers you a private healing, a special status, or says sex or touching will heal you, that's a signal to leave the room and tell your companion."
Watch for: idealising a particular shaman, or wanting to be "chosen". It's working if the client can name the warning signs and has a concrete exit and companion plan.

4.8 Safety and support plan

Purpose / when: Phase C. This adapts the safety and support plan and transportation plan required in Oregon's regulated preparation session. [source: Oregon fact sheet] [synthesis: content]
Steps: Write down: (1) emergency contacts at home and someone who knows the itinerary; (2) the travelling companion; (3) the local emergency number, nearest hospital and embassy contact; (4) travel insurance and whether it covers the activity; (5) a plan for leaving early, including money for independent transport; (6) a crisis plan if suicidal thoughts return; (7) a rule against swimming or going near water unsupervised after ceremonies (ICEERS reports drownings it considers preventable with supervision); (8) the booked return check-in.
Example language (illustrative): "Let's plan as if something goes wrong, so you don't have to work it out while you're vulnerable."
Watch for: solo travel to a remote site with no independent exit. It's working if the plan is written down, shared with the companion, and the client knows where it is.

4.9 Preparing for difficult experiences

Purpose / when: Phase C. PHRI names working with difficult experiences as a core component. [source: Gorman et al. 2021, abstract] [synthesis: method]
Steps: (1) Normalise that frightening, grief-laden or bodily-distressing states are common. (2) Teach grounding skills the client already knows from therapy (breath, orienting to the senses, a self-statement). (3) Agree when to ask for help: chest pain, confusion that doesn't pass, injury, wanting to harm self or others, or being touched without consent. (4) Rehearse asking a named staff member for help. (5) Remind the client that nobody is obliged to keep talking or interacting with others. [source: Chacruna on personal space]
Example language (illustrative): "If it gets very hard, your job isn't to fight it or to push through anything a facilitator tells you to. It's to stay safe and ask for help if you need it."
Watch for: beliefs that "surrender" means accepting anything a facilitator does. It's working if the client can tell the difference between a hard inner experience and an unsafe outer situation.

4.10 Return triage session

Purpose / when: Phase E, ideally within the first few days of return, by phone if needed. This mirrors Oregon's required follow-up within 72 hours. [source: Oregon fact sheet] [synthesis: content]
Steps: (1) Check physical state: ongoing vomiting, dehydration, injuries, chest symptoms. Refer medically if present. (Dehydration with heat exposure was the ruled cause in the Miami Beach death. [source: CBS Miami 2026]) (2) Run a standard suicide-risk assessment. (3) Screen for psychotic symptoms, mania, severe insomnia and persistent derealisation or depersonalisation. (4) Ask directly and neutrally whether anything happened that felt wrong, including touch, pressure, or substances they didn't expect. (5) Confirm the prescriber's plan for restarting medication. (6) Book integration sessions or an urgent referral.
Example language (illustrative): "Before we get into what it meant, how are you sleeping and eating, and is there anything from the retreat that's worrying you, including how anyone treated you?"
Watch for: euphoria that hides risk, ideas of reference, grandiosity, or no sleep. These may indicate an emerging psychotic or manic episode and need same-day psychiatric assessment [synthesis]. Triage has done its job when acute risks are excluded or referred.

4.11 Narrative integration

Purpose / when: Phase F, the core integration work. Clients often come back with intense but fragmented material. [synthesis]
Steps: (1) Invite a free account in the client's own words, and don't interpret the ceremony or its cultural or religious meanings for them. (2) Note the emotions, images and themes that link to existing therapy goals. (3) Ask what feels unresolved or frightening. (4) Use your usual modality (for example CBT, ACT, psychodynamic or IFS-informed work) to process these themes. (5) Encourage journalling or creative expression between sessions if useful.
Example language (illustrative): "Tell it however it comes. We don't need to decide what it means yet."
Watch for: the client being told by facilitators what their experience "means", and rigid new belief systems forming. Integration is working when the story becomes more coherent and connected to everyday life.

4.12 Separating insight from impulse (decision delay)

Purpose / when: Phase F. This extends Chacruna's advice to allow time for integration before sexual or romantic decisions to all major decisions: leaving a partner or job, moving, giving away money, joining a community, or returning to the retreat. [source: Chacruna guide] [synthesis: the extension]
Steps: (1) List the decisions the client is considering. (2) Agree a cooling-off period before acting on irreversible ones. (3) Test each idea against the client's values on an ordinary day. (4) Break worthwhile insights into small, reversible behaviour changes. (5) Review them over several sessions.
Example language (illustrative): "If this is a true insight, it will still be true in a couple of months. Let's see how it holds up on an ordinary Tuesday."
Watch for: pressure from the retreat to book more ceremonies, buy training or move into the community. It's working if changes are gradual and chosen, and can be reversed.

4.13 Managing persistent after-effects

Purpose / when: anxiety, low mood, sleep disturbance, perceptual changes, depersonalisation, intrusive memories, or spiritual or existential distress lasting beyond the first weeks. Bouso et al. found psychological effects common, with about 12% seeking professional support. [source: Bouso et al. 2022] [synthesis: management]
Steps: (1) Assess severity and how it is affecting function. (2) Give psychoeducation that such effects are reported and often settle. (3) Use grounding and anxiety-management skills, sleep routines, and cutting down stimulants and further substance use. (4) For trauma intrusions, use stabilisation before any processing. (5) Refer for psychiatric assessment if symptoms are psychotic, manic, severe or persistent, and for medical review if perceptual disturbances persist.
Example language (illustrative): "What you're describing has been reported by other people after retreats. We'll take it seriously and work to steady things first."
Watch for: the client being told by the retreat that symptoms are "purging" or "energy" that needs more ceremony. It's working if symptoms fall and function returns.

4.14 Responding to a disclosure of sexual abuse or exploitation

Purpose / when: any disclosure, including a delayed one, or one the client is not sure was abuse. Chacruna notes that freezing is common and that recognition often comes later. [source: Chacruna guide; Peluso et al. 2022 on shame and confusion]
Steps: (1) Listen and believe. Name that a healer's position of trust makes this an abuse of power, whatever the claimed consent. [source: Chacruna] (2) Assess immediate safety and medical needs (sexual health, pregnancy, injury). (3) Explain options without pressure: reporting to local police, to the home country's embassy or police, civil action, or Chacruna's Legal Resource Companion for country-specific information. [source: Chacruna guide] (4) Help the client preserve records (messages, receipts, names, dates). (5) Offer trauma-focused treatment once the client is stable. (6) Follow your own mandatory-reporting rules where they apply (for example, a minor or a vulnerable adult).
Example language (illustrative): "What you're describing wasn't healing. It was someone using their position. You get to decide what happens next, and I'll help with whatever you choose."
Watch for: self-blame ("I was high, I agreed"), and loyalty to the healer or community. It's working when blame moves to the perpetrator and the client makes choices for themselves.

4.15 Cultural humility and reciprocity reflection

Purpose / when: clients drawn to Indigenous ceremonies, or returning with spiritual frameworks. Chacruna describes romanticised images of shamans, commercialisation and cross-cultural misreading as contributors to harm. ICEERS calls for supporting Indigenous communities. Indigenous organisations speak for themselves on this: a 2019 declaration by UMIYAC and other Amazonian organisations (on behalf of the Siona, Inga, Coreguaje, Kamentsá-Biya and Cofán peoples) rejects ayahuasca tourism, retreats and "shamanism schools" run by outsiders without traditional knowledge, and states that no Indigenous authority certifies outsiders to lead yagé ceremonies; the 2025 Fifth Indigenous Ayahuasca Congress letter rejects "uncontrolled commercialization of ayahuasca" and asks for free, prior and informed consultation. Chacruna notes that Indigenous views differ, with some communities welcoming paid partnerships. [source: UMIYAC 2019; ICEERS 2025; Chacruna 2019] [synthesis: method]
Steps: (1) Explore what the client understands about the tradition and who holds authority in it. (2) Treat spiritual beliefs as the client's and the tradition's own, without endorsing or debunking them. (3) Discuss how commercial "neo-shamanic" retreats differ from community-held practice, as far as reliable information exists. (4) Encourage the client to learn from the communities' own published sources (such as the declarations above), without presenting any one statement as all Indigenous opinion. [synthesis]
Example language (illustrative): "What do you know about who this tradition belongs to, and how the people running your retreat are connected to it?"
Watch for: the clinician interpreting sacred content, which is out of scope. It's working if the client's account is more nuanced and less exoticised.

4.16 Financial and coercive-control review

Purpose / when: the client is being asked for large fees, repeat bookings, "facilitator trainings", donations, or to sign broad waivers. Examples in the sources include a $2,000 fee plus a signed waiver in the Miami Beach case, and $10,800 plus $6,300 for the Galisteo "energy medicine" training. [source: CBS Miami 2026; Santa Fe New Mexican] Chacruna's commodification checklist asks, among other things, whether pricing is fair, whether well-being comes before profit, whether marketing is sensationalistic, and whether participants are pressured into extra payments or investments. [source: Chacruna 2019] [synthesis: method]
Steps: (1) Map the total money spent and committed. (2) Look at how the client is being pressured (urgency, special status, "your healing depends on it"). (3) Check for isolation from family and friends, or demands for secrecy. (4) Review the offer against Chacruna's questions above. (5) Support refund or consumer complaints where they are possible.
Example language (illustrative): "Let's add up what this has cost so far, and look at how the next step is being sold to you."
Watch for: high-control group dynamics, such as isolation from family and friends, escalating payments and pressure to stay (see Section 5). It's working if spending stops and outside relationships come back.

5. Handling problems

Most of this section is [synthesis]; the sources address few of these problems directly. Sourced points are tagged.

Client won't disclose plans, or discloses only afterwards. Restate your non-judgemental stance [source: Gorman et al. 2021]. Make psychedelic use a routine assessment question, and do return triage (4.10) whenever you learn of use after the fact. Don't shame them for not telling you.
Client insists on going despite high risk (psychosis history, cardiac disease, interacting medication). Tell them plainly that you advise against it, and why. Offer a medical review. Document the conversation. Keep the relationship going, and still do safety planning (4.8) and sexual-safety planning (4.7): harm reduction doesn't depend on agreement. If the client is currently psychotic, manic or acutely suicidal, assess capacity and use your usual crisis pathways.
Client asks you to recommend a retreat, a dose or a source. Decline clearly and explain that it's outside your role. Offer to help them write due-diligence questions instead (4.6). Name regulated or trial options where they exist (for example Oregon's licensed programme [source: Oregon fact sheet]).
Retreat has told the client to stop medication. Refer to the prescriber straight away and contact them with consent. Warn the client in general terms about withdrawal and relapse. Never set a schedule yourself. [source: AP 2026 on unsupervised washout requirements]
Idealisation of a shaman, guru or facilitator, or devaluing therapy by comparison. Explore it as you would any idealising transference. Use Chacruna's "He's a Shaman, Not a Saint!" framing. Watch for grooming signs (special status, secrecy, private sessions). [source: Chacruna guide]
Rupture: client feels judged, or that you are "against the medicine". Name the rupture, acknowledge any judgemental moments of your own, and restate that your concern is their safety, not policing their choices. [synthesis; stance from Gorman et al.]
Overwhelm after return (panic, flashbacks, depersonalisation). Stabilise first: grounding, sleep, cut down on substances, and see the client more often. Hold off trauma processing. Refer to psychiatry for severe, psychotic or persistent symptoms (4.13).
Emerging psychosis or mania after a retreat. Arrange same-day psychiatric assessment, involve family or the companion with consent, and stop further substance use. Retreats that frame such symptoms as spiritual awakening may delay care; reliable sources link severe psychiatric disorders to bad outcomes. [source: ICEERS on psychiatric history as a risk factor]
Suicidality after a retreat. Use standard risk assessment and safety planning, including lethal-means counselling (secure storage and removal). ICEERS cautions that most media-linked suicides lacked confirmed ayahuasca use shortly beforehand, so don't assume cause, but always treat the risk. [source: ICEERS / Suárez Álvarez 2023]
Spiritual emergency or new belief system disrupting life. Respect the client's beliefs, separate distressing experience from risky behaviour, and use decision delay (4.12). Consult a clinician experienced in spiritual or religious issues if needed.
Client stuck in "more ceremonies will fix it". Explore what the previous ones did and didn't change. Notice escalation or dependence on the community, and the money involved (4.16). Bring the focus back to everyday change.
Abuse disclosure combined with continued loyalty to the community. Don't force the client to choose. Work at their pace, and keep the reporting options open (4.14).
Clinician's own countertransference (enthusiasm, fascination, alarm, moral disapproval). Take it to supervision. Your excitement can work as an endorsement, and alarm can drive the client away. [synthesis]
Legal and ethical uncertainty for the clinician. Check your licensing board, professional code and employer policy on discussing illegal drug use. Get supervision. Keep documentation factual. Don't help with travel, purchase or contact with providers.

Harm account

This account draws on major journalism, a court filing reported in the press, a peer-reviewed survey, a qualitative interview study (JAMA Network Open), reports by ICEERS and Chacruna, organisations that support ayahuasca use and so tend to present its safety favourably (weigh them accordingly), and Indigenous organisations' own declarations. Charges and lawsuit claims are allegations unless a source reports a conviction or judgement. No doses, routes or administration details are given.

What was actually done

Deaths after ceremonies. ICEERS (Suárez Álvarez, 2023) reviewed 58 deaths linked to ayahuasca by the media between 2010 and 2022. Only 34 confirmed ayahuasca use in the hours before death, and none of the nine public autopsies attributed death to acute ayahuasca intoxication. The documented circumstances in the other cases included: tobacco preparations given in ceremony (4 cases); brews or admixtures containing scopolamine-bearing Brugmansia (one confirmed scopolamine death, two suspected); a fatal synthetic 5-MeO-DMT intoxication hours after ayahuasca; water intoxication (hyponatraemia); drownings after ceremonies, which ICEERS judges preventable with supervision; a fatal neck fracture during convulsions in a trance, which ICEERS also considers potentially preventable with supervision; and two autopsy-confirmed heart attacks, one in a man with Marfan syndrome. ICEERS concluded that in the few cases where ayahuasca played a part, most deaths could have been prevented by minimum safety standards. [source: ICEERS summary and article]
Miami Beach, 2025 (criminal case, allegations). CBS News Miami (14 Jul 2026) reported that Dr. Samuel Lee was arrested on a second-degree felony manslaughter charge over the death of a woman participant on 10 Feb 2025. She was found unresponsive in a rooftop sauna at a private wellness home after a three-day retreat called the "Heart Protocol". It was promoted as helping participants "connect with their higher selves", she paid a $2,000 fee, and she signed a waiver. Lee allegedly gave MDMA and ketamine. The Miami-Dade Medical Examiner ruled the cause of death as dehydration, with the two drugs, prolonged sauna heat and a pre-ceremony cleansing regimen as contributing factors. A physician consulted by police described an "extreme and unjustifiable deviation" from safe clinical practice. Lee pleaded not guilty. The operator, Sabia Wellness, said through its attorney that the State Attorney's Office had found it not culpable. [source: CBS Miami 2026] No outcome was known at the time of the source.
Sexual abuse by healers and facilitators. Chacruna's guide, based on input from survivors, healers, facilitators and researchers, describes recurring tactics: focusing on looks and excessive touching; claiming a wife doesn't mind; pacts of silence; offering "love magic" or using charm techniques; claiming ayahuasca enhances sex; calling the participant "special" or "chosen", or offering ceremonial status; promoting "tantric" exercises or sexual contact as trauma healing; offering extra substances presented as treatments for "energy imbalances" or "sexual chakra releases"; and arranging individual treatments alone or outside ceremony. The guide describes harms ranging from verbal persuasion and invasive touching to coerced "consensual" sex and rape. [source: Chacruna guide; Peluso et al. 2022] [uncertain: prevalence is not established in the sources cited]
Galisteo, New Mexico (civil lawsuit, allegations). The Santa Fe New Mexican reported a civil complaint by a plaintiff identified as M.G. against the Four Winds Society and The Chi Center. It alleges that during a paid one-on-one session at a March 2023 "energy medicine" training, a man described as a "shamanic master" sexually assaulted her after she disclosed childhood abuse. It alleges that at least two other women had similar experiences, and that a senior teacher was told and informed the owner. The man is not named and has not been charged. A sheriff's investigation went inactive after he reportedly left the US. The defendants did not comment. [source: Santa Fe New Mexican] These are unproven allegations.
Psychological crises. In the Global Ayahuasca Survey (n = 10,836), 55.9% reported psychological effects in the weeks or months after use. About 12% sought professional support, and 2.3% needed medical attention for physical effects. [source: Bouso et al. 2022]
Violence and crime. The US Embassy in Peru (Jan 2025) cited crimes linked to retreat centres. [source: DoubleBlind 2025] In December 2015 a Canadian participant fatally stabbed a British participant after an ayahuasca ceremony at a retreat in the Peruvian Amazon; investigators concluded he acted in self-defence and released him. [source: CBC, 21 Dec 2015] In April 2018 an elderly Shipibo-Conibo healer who had worked at a retreat centre was shot dead in Ucayali; villagers accused a Canadian former client studying plant medicine, who was then killed by a mob. Both killings were under investigation, with no conviction reported; the motive was unconfirmed and disputed by her family. [source: wire report via Yahoo News, April 2018] Neither event shows anything about the substance itself; both show the absence of security and crisis management in some settings. [synthesis]
Unsupervised medication changes and uneven safety practice. McGuire et al. (JAMA Network Open, 2026) interviewed 49 organisations advertising retreats (2023): all collected medical histories and 73.5% excluded some health conditions; 87.8% required or recommended a medication washout; 38.7% offered more than one psychedelic; 69.4% worked with a licensed health professional or someone with emergency training, and 65.3% had such a person present at least some of the time. The authors report "substantial variability" and flag some washout and polysubstance practices as possibly increasing risk. [source: McGuire et al. 2026, abstract] A commentary on the study adds that the most common exclusions were psychosis and bipolar disorder, that suggested washout periods ranged from one day to more than six weeks, and that every organisation offered some integration support, often optional and loosely structured. [source: Lazarus, KevinMD 2026] [uncertain: secondary] AP adds that screening relied on self-disclosure and that in some retreats staff took psychedelics alongside participants. [source: AP 2026]
Financial exploitation. Documented cases pair high fees with waivers ($2,000 in Miami Beach; $17,100 combined in Galisteo). [source: CBS Miami; Santa Fe New Mexican] Chacruna notes that fees can exclude poorer participants and create inequalities within local Amazonian communities, and lists pressure on participants to make extra payments or investments among its warning questions. [source: Chacruna 2019] The UMIYAC declaration describes young people with superficial training adopting traditional dress and titles to seek profit, endangering patients. [source: UMIYAC 2019] [uncertain: no systematic study of financial exploitation, upselling or debt among participants is cited here]
Cultural extraction. Chacruna names the commercialisation of ayahuasca, romanticised images of shamans and economic inequality as contributors to abuse, and ICEERS calls for supporting Indigenous communities. [source: Chacruna; ICEERS] In their own words: the 2019 UMIYAC declaration (UMIYAC, COICA, ASOMI, OZIP, OPIAC, ASMIC and the Inga territorial entity) holds that yagé is collective Indigenous heritage that should not be sold for profit outside lineage practitioners endorsed by their communities, criticises commercial harvesting of the plants, and names three European organisations (European Ayahuasca School, Inner Mastery, Verein Sol Jaguar) as marketing yagé. [source: UMIYAC 2019; these are the declaration's accusations, unverified, and the organisations' responses are not reported here] The 2025 Fifth Indigenous Ayahuasca Congress letter denounces commodification of Indigenous knowledge and asks that patents and biomedical uses of ancestral knowledge not proceed without its custodians. [source: ICEERS, Domsac, 23 Jun 2025] McGuire et al. recommend that safety guidelines be co-developed with Indigenous communities. [source: McGuire et al. 2026] [uncertain: no peer-reviewed study of community impact or plant sustainability is cited here]

How it caused harm

Medical mechanisms: extra substances or admixtures (tobacco preparations, scopolamine-containing plants, synthetic tryptamines); interactions with medications such as antidepressants; pre-existing cardiovascular and other serious illness; dehydration and heat exposure; water intoxication; unsupervised water exposure; injury during convulsions or impaired states. [source: ICEERS; CBS Miami]
Psychiatric mechanisms: psychiatric history, especially schizophrenia or a tendency to psychosis, is flagged as a risk factor. Anxiety disorders, physical health conditions and stronger acute spiritual experiences predicted adverse psychological effects. Use in religious settings predicted fewer. [source: ICEERS; Bouso et al. 2022]
Abuse mechanisms: a healer's power and trust; participants' altered state, suggestibility, euphoria or induced attraction; freezing; shame and confusion that delay recognition; cross-cultural power gaps; and the fact that many women come seeking healing from sexual trauma, which deepens the injury. [source: Chacruna guide; Peluso et al. 2022]
Systemic mechanisms: no industry-wide standards for screening, preparation or aftercare; self-report screening; vague medical roles; unproven legal claims; remote sites far from hospitals. [source: AP 2026; DoubleBlind on Costa Rica's lack of licensing]
Most at risk: people with psychotic, bipolar or severe psychiatric histories, cardiac or serious illness, or on interacting medication; women, especially survivors of sexual trauma; people in acute crisis looking for rescue; people with substance use disorders; and solo travellers to remote sites. [source: ICEERS; Bouso; Chacruna] [synthesis: the combined list]

Recognising it today

Red flags in a retreat, facilitator or group:

Screening that is only a self-report form, or none at all. Being told to stop medications without your prescriber's involvement. [source: AP 2026]
No named medical lead, no emergency or transport plan, or a site far from a hospital. Staff who use substances during ceremonies. [source: AP 2026]
Substances added beyond those advertised, "special" brews, or private extra "medicines". Several different psychedelics offered in one programme, a practice McGuire et al. flag as possibly higher risk. [source: ICEERS; Chacruna; McGuire et al. 2026]
Outsiders or short-course graduates presenting as "shamans" or claiming Indigenous certification. UMIYAC states that no Indigenous authority certifies outsiders to lead yagé ceremonies. [source: UMIYAC 2019]
Individual or after-hours treatments alone with a healer. Touching private areas or removing clothing as part of "cleansing". Sex framed as healing, "tantric" or chakra work. Secrecy pacts. Being "chosen" for special status. [source: Chacruna guide]
Broad waivers, large upfront fees, pressure to book more ceremonies or trainings, and marketing promises of transcendence ("higher selves"). [source: CBS Miami; Santa Fe New Mexican] [synthesis: generalisation]
Claims of legal or religious protection that can't be checked. [source: AP 2026]
Interpreting psychotic or manic symptoms as "purging" or "awakening" that needs more ceremony. [synthesis]
Rebrandings to watch for [synthesis]: "plant-medicine wellness", "heart-opening protocol", "energy medicine training", "breakthrough intensive", and home or private-villa "ceremonies" run by credentialed professionals outside any regulated framework (as in the Miami Beach case).

How legitimate versions differ: regulated programmes such as Oregon's have licensed facilitators and service centres, required preparation with informed consent, a client bill of rights, safety and transportation plans, a minimum client-to-facilitator ratio in groups, and follow-up within 72 hours. [source: Oregon fact sheet] Clinical trials add independent medical screening and oversight [synthesis]. Reputable ceremonial settings make sure experienced women are present to safeguard female participants and respect the right to say no. [source: Chacruna guide]

What to do instead and how to help those harmed

Safer alternatives: not going; regulated programmes where they are legal (for example Oregon Psilocybin Services [source: Oregon fact sheet]); registered clinical trials; and evidence-based non-drug psychotherapies for the condition the client wants help with. [synthesis]
Assessment of affected clients: physical health; suicide risk; psychotic, manic and dissociative symptoms; trauma symptoms; substance use; medication status; financial losses; and any continuing contact with the group. [synthesis]
Treatment: stabilise first; then use trauma-focused therapy for sexual abuse or traumatic experiences; psychiatric care for psychosis or mania; and grief work for bereaved families (including families of people who died at retreats). Address shame and self-blame directly. [synthesis]
Reporting and legal routes: local police in the destination; the home country's embassy; home-country police where the law reaches offences abroad; civil lawyers; health regulators (Costa Rica's Ministry of Health asks for reports of unlicensed retreats [source: DoubleBlind 2025]); professional licensing boards if a licensed clinician was involved (the Miami prosecutors asked the court to bar the accused doctor from practising medicine while the case is pending [source: CBS Miami]); and Chacruna's Legal Resource Companion for country-specific information [source: Chacruna guide].
Clinician duties: follow mandatory reporting where it applies (minors, vulnerable adults, threats to others); keep confidentiality otherwise; document disclosures factually; support, but don't pressure, a decision to report; and if a colleague is involved in unsafe or illegal facilitation, follow your professional code's reporting duties. [synthesis]

Sources

Web sources:

Further web sources:

Further cited works [uncertain where relied on]: Gorman et al. 2021 and McGuire et al. 2026 (abstracts used); the US Embassy Peru and Costa Rica Ministry of Health advisories (secondary reports used); Chacruna's 2023 sexual-abuse survey and Legal Resource Companion; the Dutch truffle exemption, Jamaica's Dangerous Drugs Act and Brazil's ayahuasca resolutions (secondary or government news reports used).

← Previous · VII-069Psychedelic microdosing Next · VII-071 →Psychedelic integration therapy